Effectiveness of pharmacological or psychological interventions for smoking cessation in smokers with major depression or depressive symptoms: A systematic review of the literature

References

• Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ. Extended treatment of older cigarette smokers. Addiction. 2009;104(6):1043–1052. doi:10.1111/j.1360-0443.2009.02548.x. PMID:19392908.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatry. 1993;50(1):36–43. doi:10.1001/archpsyc.1993.01820130038007. PMID:8422220.
   PubMed Web of Science ®Google Scholar
• Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking: a longitudinal investigation. Arch Gen Psychiatry. 1998;55(2):161–166. doi:10.1001/archpsyc.55.2.161. PMID:9477930.
   PubMed Web of Science ®Google Scholar
• Markou A, Kenny PJ. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res. 2002;4(4):297–313. doi:10.1080/10298420290023963. PMID:12829420.
   PubMed Web of Science ®Google Scholar
• Cosci F, Nardi AE, Griez EJL. Nicotine effects on human affective functions: a systematic review of the literature on a controversial issue. CNS Neurol Disord Drug Targets. 2014;13(6):981–991. doi:10.2174/1871527313666140612105254. PMID:24923344.
   PubMed Web of Science ®Google Scholar
• Mathew AR, Hogarth L, Leventhal AM, Cook JW, Hitsman B. Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model. Addiction. 2016;112(3): 401–412. doi:10.1111/add.13604. PMID:27628300.
   PubMed Web of Science ®Google Scholar
• Bolam B, West R, Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res. 2011;13(3):209–214. doi:10.1093/ntr/ntq244. PMID:21330275.
   PubMed Web of Science ®Google Scholar
• Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW Jr. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med. 2012;27(3):351–360. doi:10.1007/s11606-011-1915-2. PMID:22038468.
   PubMed Web of Science ®Google Scholar
• Weinberger AH, Mazure CM, Morlett A, McKee SA. Two decades of smoking cessation treatment research on smokers with depression: 1990–2010. Nicotine Tob Res. 2013;15(6):1014–1031. doi:10.1093/ntr/nts213. PMID:23100459.
   PubMed Web of Science ®Google Scholar
• Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108(2):294–306. doi:10.1111/add.12009. PMID:23072580.
   PubMed Web of Science ®Google Scholar
• Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction. 2012;107(10):1847–1856. doi:10.1111/j.1360-0443.2012.03889.x. PMID:22429388.
   PubMed Web of Science ®Google Scholar
• Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357(9272):1929–1932. doi:10.1016/S0140-6736(00)05064-9. PMID:11425414.
   PubMed Web of Science ®Google Scholar
• Bech P. Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom. 2010;79(6):331–338. doi:10.1159/000320118. PMID:20733343.
   PubMed Web of Science ®Google Scholar
• Lichtenberg P, Belmaker RH. Subtyping major depressive disorder. Psychother Psychosom. 2010;79(3):131–135. doi:10.1159/000286957. PMID:20185969.
   PubMed Web of Science ®Google Scholar
• van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;(8):CD006102. PMID:23963776.
   PubMed Web of Science ®Google Scholar
• Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82(1):20–34. doi:10.1159/000342243. PMID:23147126.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:10.1371/journal.pmed.1000100. PMID:19621070.
   PubMed Web of Science ®Google Scholar
• Thorsteinsson HS, Gillin JC, Patten CA, Golshan S, Sutton LD, Drummond S, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with depression. Neuropsychopharmacology. 2001;24(4):350–358. doi:10.1016/S0893-133X(00)00217-7. PMID:11182530.
   PubMed Web of Science ®Google Scholar
• Hall SM, Tsoh JY, Prochaska JJ, Eisendrath S, Rossi JS, Redding CA. et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;96(10):1808–1814. doi:10.2105/AJPH.2005.080382. PMID:17008577.
   PubMed Web of Science ®Google Scholar
• Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013;159(8):390–400. doi:10.7326/0003-4819-159-6-201309170-00005. PMID:24042367.
   PubMed Web of Science ®Google Scholar
• Blondal T, Gudmundsson LJ, Tomasson K, Jonsdottir D, Hilmarsdottir H, Kristjansson F, et al. The effects of fluoxetine combined with nicotine inhalers in smoking cessation—a randomized trial. Addiction. 1999;94(7):1007–1015. doi:10.1046/j.1360-0443.1999.94710076.x. PMID:10707439.
   PubMed Web of Science ®Google Scholar
• Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. Int J Psychiatry Med. 2008;38(3):373–389. doi:10.2190/PM.38.3.k. PMID:19069579.
   PubMed Web of Science ®Google Scholar
• Walsh Z, Epstein A, Munisamy G, King A. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. J Addict Dis. 2008;27(1):65–72. doi:10.1300/J069v27n01_07. PMID:18551889.
   PubMed Web of Science ®Google Scholar
• Batra A, Collins SE, Schröter M, Eck S, Torchalla I, Buchkremer G. A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups. J Subst Abuse Treat. 2010;38(2):128–140. doi:10.1016/j.jsat.2009.08.003. PMID:19819661.
   PubMed Web of Science ®Google Scholar
• MacPherson L, Tull MT, Matusiewicz AK, Rodman S, Strong DR, Kahler CW, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2012;78(1):55–61. doi:10.1037/a0017939.
   Web of Science ®Google Scholar
• Schleicher HE, Harris KJ, Campbell DG, Harrar SW. Mood Management Intervention for college smokers with elevated depressive symptoms: a pilot study. J Am Coll Health. 2012;60(1):37–45. doi:10.1080/07448481.2011.567403. PMID:22171728.
   PubMed Web of Science ®Google Scholar
• Brown RA, Abrantes AM, Strong DR, Niaura R, Kahler CW, Miller IW, et al. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers. Nicotine Tob Res. 2014;16(2):197–207. doi:10.1093/ntr/ntt134. PMID:24057928.
   PubMed Web of Science ®Google Scholar
• Bernard P, Ninot G, Cyprien F, Courtet P, Guillaume S, Georgescu V, et al. Exercise and counseling for smoking cessation in smokers with depressive symptoms: a randomized controlled pilot trial. J Dual Diagn. 2015;11(3-4):205–216. doi:10.1080/15504263.2015.1113842. PMID:26683252.
   PubMed Web of Science ®Google Scholar
• Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62(1):141–146. doi:10.1037/0022-006X.62.1.141. PMID:8034816.
   PubMed Web of Science ®Google Scholar
• Hall SM, Muñoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996;64(5):1003–1009. doi:10.1037/0022-006X.64.5.1003. PMID:8916629.
   PubMed Web of Science ®Google Scholar
• Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, et al. Nortriptyline and cognitive–behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55(8):683–690. doi:10.1001/archpsyc.55.8.683. PMID:9707377.
   PubMed Web of Science ®Google Scholar
• Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis. 1999;18(1):31–40. doi:10.1300/J069v18n01_04. PMID:10234561.
   PubMed Web of Science ®Google Scholar
• Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry. 1999;174:173–178. doi:10.1192/bjp.174.2.173. PMID:10211174.
   PubMed Web of Science ®Google Scholar
• Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, et al. Cognitive–Behavioral Treatment for depression in smoking cessation. J Consul Clin Psychol. 2001;69(3):471–480. doi:10.1037/0022-006X.69.3.471.
   PubMed Web of Science ®Google Scholar
• Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry. 2002;159(10):1731–1737. doi:10.1176/appi.ajp.159.10.1731. PMID:12359680.
   PubMed Web of Science ®Google Scholar
• Hall SM, Humfleet GL, Reus VI, Muñoz RF, Hartz DT, Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry. 2002;59(10):930–936. doi:10.1001/archpsyc.59.10.930. PMID:12365880.
   PubMedGoogle Scholar
• Smith SS, Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nic Tob Res. 2003;5(1):99–109. doi:10.1080/1462220021000060437.
   PubMed Web of Science ®Google Scholar
• Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med. 2004;19(8):828–834. doi:10.1111/j.1525-1497.2004.30423.x. PMID:15242467.
   PubMed Web of Science ®Google Scholar
• Haas AL, Muñoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consul Clin Psychol. 2004;72(4):563–570. doi:10.1037/0022-006X.72.4.563.
   PubMed Web of Science ®Google Scholar
• Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addict. 2004;13(5):438–446. doi:10.1080/10550490490512762. PMID:15764422.
   PubMed Web of Science ®Google Scholar
• Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, et al. Bupropion and cognitive–behavioral treatment for depression in smoking cessation. Nicotine Tob Res. 2007;9(7):721–730. doi:10.1080/14622200701416955. PMID:17577801.
   PubMed Web of Science ®Google Scholar
• Spring B, Doran N, Pagoto S, McChargue D, Cook JW, Bailey K, et al. Fluoxetine, smoking, and history of major depression: a randomized controlled trial. J Consult Clin Psychol. 2007;75(1):85–94. doi:10.1037/0022-006X.75.1.85. PMID:17295567.
   PubMed Web of Science ®Google Scholar
• Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, et al. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction. 2008;103(8):1381–1390. doi:10.1111/j.1360-0443.2008.02273.x. PMID:18855829.
   PubMed Web of Science ®Google Scholar
• Weinberger AH, Reutenauer EL, Jatlow PI, O'Malley SS, Potenza MN, George TP. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine dependent cigarette smokers. Drug Alcohol Depend. 2010;107(2-3):188–195. doi:10.1016/j.drugalcdep.2009.10.009. PMID:19939587.
   PubMed Web of Science ®Google Scholar
• Jane-Wit D, Horwitz RI, Concato J. Variation in results from randomized, controlled trials: stochastic or systematic? J Clin Epidemiol. 2010;63(1):56–63. doi:10.1016/j.jclinepi.2009.02.010. PMID:19740624.
   PubMed Web of Science ®Google Scholar
• Fava GA, Guidi J, Rafanelli C, Sonino N. The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgement. Psychother Psychosom. 2015;84(1):1–3. doi:10.1159/000366041. PMID:25547189.
   PubMed Web of Science ®Google Scholar
• Tomba E, Fava GA. Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am. 2012;35(1):87–98. doi:10.1016/j.psc.2011.11.003. PMID:22370492.
   PubMed Web of Science ®Google Scholar
• Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016;173(2):128–137. doi:10.1176/appi.ajp.2015.15040476. PMID:26481173.
   PubMed Web of Science ®Google Scholar
• Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Can treatment that is helpful on average be harmful to some patients? J Clin Epidemiol. 1996;49(4):395–400. doi:10.1016/0895-4356(95)00058-5. PMID:8621989.
   PubMed Web of Science ®Google Scholar
• Richardson WS, Doster LM. Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. J Clin Epidemiol. 2014;67(3):244–246. doi:10.1016/j.jclinepi.2013.10.020. PMID:24472294.
   PubMed Web of Science ®Google Scholar
• Fava GA, Cosci F, Tomba E. Iatrogenic comorbidity in mental health. Psychother Psychosom. 2015;84(Suppl 1):22. PMID:25547421.
   PubMedGoogle Scholar
• Fava GA, Cosci F, Offidani E, Guidi J. Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment. J Clin Psychopharmacol. 2016;36(6):550–553. doi:10.1097/JCP.0000000000000570. PMID:27631576.
   PubMed Web of Science ®Google Scholar
• Cosci F, Fava GA. New clinical strategies of assessment of comorbidity associated with substance use disorders. Clin Psychol Rev. 2011;31(3):418–427. doi:10.1016/j.cpr.2010.11.004. PMID:21122963.
   PubMed Web of Science ®Google Scholar
• Roth M, Mountjoy CQ. The distinction between anxiety states and depressive disorders. In: Paykel ES, ed. Handbook of Affective Disorders. New York, NY: Guilford Press; 1982:70–92.
   Google Scholar
• Fava GA, Rafanelli C, Tomba E. The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry. 2012;73(2):177–184. doi:10.4088/JCP.10r06444. PMID:21903024.
   PubMed Web of Science ®Google Scholar